Understanding Ductal Adenocarcinoma of the Pancreas
Ductal adenocarcinoma of the pancreas, often called pancreatic ductal adenocarcinoma or PDAC, represents the vast majority of pancreatic cancer cases. This type of cancer begins in the cells that line the small tubes inside the pancreas called ducts, which are responsible for carrying digestive juices containing enzymes into the main pancreatic duct and then into the small intestine. These digestive juices help break down the food we eat so the body can use its nutrients.[3][4]
The pancreas is a fish-shaped gland about six inches long that sits behind the stomach, nestled between the spine and stomach. It has two main jobs in the body: making digestive enzymes and producing hormones like insulin and glucagon that help control blood sugar levels. When cancer develops in the ducts of this organ, it’s classified as an exocrine cancer, meaning it starts in cells that produce digestive substances rather than hormones.[1][11]
About 95 out of 100 pancreatic cancers are exocrine cancers, and the overwhelming majority of these are ductal adenocarcinomas. The term adenocarcinoma means cancer that begins in glandular tissue that lines many organs, including the pancreas. Although PDAC can develop anywhere in the pancreas, it most commonly appears in the head of the pancreas, which is the wider end closest to the small intestine.[3][5]
Epidemiology: Who Gets This Disease
Pancreatic ductal adenocarcinoma is one of the deadliest forms of cancer affecting people worldwide. It ranks as the fourth most common cause of cancer-related deaths globally and is almost always fatal when diagnosed in advanced stages. The disease is particularly concerning because its incidence is expected to rise significantly in the coming years.[4][6]
Projections indicate that pancreatic cancer will become the second leading cause of cancer death in the United States by 2030. This expected increase is related partly to the general aging of the population, as pancreatic cancer rarely occurs before the age of 40, and more than half of all cases are diagnosed in people over 70 years old. In 2012, it was estimated that around 44,000 new cases were diagnosed in the United States alone, with more than 37,000 deaths from the disease in the same year. The disease affects both men and women at similar rates.[2][4][8]
Pancreatic cancer is responsible for approximately three percent of all cancers in the United States. It is the tenth most common cancer in men and the eighth most common cancer in women. Five-year survival rates remain extremely low at around eight percent, though these rates are constantly changing with new treatments. The main factor determining survival is whether it is possible to surgically remove the cancer completely.[5][8]
The incidence is expected to more than double within the next ten years, both in terms of new diagnoses and deaths related to the disease, not only in the United States but also in European countries. This rise makes pancreatic ductal adenocarcinoma a growing public health challenge that requires increased attention and resources.[6]
Causes of Ductal Adenocarcinoma of the Pancreas
The exact cause of pancreatic ductal adenocarcinoma is not completely understood. Scientists know that pancreatic cancer develops when small changes occur in the DNA of pancreatic duct cells. These changes cause cells to multiply out of control and accumulate in clusters called tumors. If left untreated, these cancer cells can spread beyond the pancreas to other parts of the body.[1]
Research has identified certain genetic mutations that play a key role in understanding pancreatic cancers. A gene called KRAS, which encodes an important signaling protein involved in cell growth and cell death, was found to be mutated in 93 percent of cancers studied. Among cancers that did not have a KRAS mutation, 60 percent had a mutation in a different gene in the same signaling pathway, known as the RAS-MAPK pathway. Another member of this pathway, a gene called RREB1, may also promote pancreatic cancer when mutated.[4]
For a small subgroup of patients, about five to six percent of all PDAC cases, genetic predispositions play a role. These include inherited mutations in genes such as BRCA1, BRCA2, ATM, MLH1, TP53, or CDKN2A. People who carry these mutations have an elevated risk of developing pancreatic cancer and may benefit from genetic testing and screening programs.[6]
Risk Factors: Who Is at Higher Risk
Several risk factors have been identified that increase the likelihood of developing pancreatic ductal adenocarcinoma. Some of these risk factors can be changed through lifestyle modifications, while others, such as age and genetics, cannot be controlled.[11]
Smoking is one of the most significant modifiable risk factors for pancreatic cancer. People who smoke cigarettes, cigars, or use other forms of tobacco are about two times more likely to develop pancreatic cancer compared to those who have never smoked. Research suggests that between 20 and 35 percent of pancreatic cancers are caused by cigarette smoking. Tobacco abuse, along with alcohol consumption, increases the risk not only for pancreatic cancer but also for other types of cancer.[6][7][8]
Being overweight or obese is another important risk factor. About 20 percent of obese individuals have an increased risk of developing pancreatic cancer, and the risk is even higher in people who have been obese since childhood. Carrying extra weight that is unhealthy for the body may contribute to cancer development. New research has found that the specific combination of smoking, diabetes, and poor diet increases the risk of pancreatic cancer more than any one factor alone.[1][7]
Diabetes is linked to pancreatic cancer in complex ways. Having diabetes, particularly new-onset diabetes in older adults, can be both a risk factor and sometimes an early sign of pancreatic cancer. Chronic inflammation of the pancreas, known as pancreatitis, also increases the risk of developing cancer in the organ over time.[1][8][11]
A family history of pancreatic cancer is another significant risk factor. About 25 percent of cases are linked to family history or genetic factors. People with certain hereditary conditions face even higher risks. These include Lynch syndrome (also called hereditary nonpolyposis colon cancer), Peutz-Jeghers syndrome, hereditary breast and ovarian cancer syndrome, familial atypical multiple mole melanoma (FAMMM) syndrome, and ataxia-telangiectasia.[11][12]
Lifestyle habits also play a role. High consumption of sugary drinks, fats, red and processed meats may increase the risk of developing pancreatic cancer. Life style factors such as alcohol abuse and poor diet contribute to the disease’s development. Obesity and type 2 diabetes, two emerging public health challenges, are also implicated in PDAC development.[6][7]
Symptoms: What to Watch For
Unfortunately, pancreatic ductal adenocarcinoma does not usually cause symptoms in the early stages. This is one of the main reasons why the disease is so deadly—by the time symptoms appear, the cancer has often already spread to other parts of the body. Symptoms typically emerge only once the tumor starts impacting other organs in the digestive system.[1][5][8]
One of the most noticeable symptoms is jaundice, which causes yellowing of the skin and the whites of the eyes. This occurs when a tumor blocks the bile duct, preventing bile from flowing properly. Along with jaundice, people may notice dark-colored urine and light-colored or clay-colored stool. Jaundice can also cause severe itching of the skin.[5][7][8]
Pain is another common symptom. Many people with pancreatic cancer experience pain in the upper abdomen or middle back. This pain may spread from the stomach area to the back. The pain can come and go at first but may worsen after eating or when lying down. Some people develop vague symptoms up to one year before they receive a diagnosis, with back pain or stomach pain being among the first signs they notice.[5][7][8]
Unexplained weight loss is a frequent symptom of pancreatic cancer. People may lose weight without trying, often accompanied by a loss of appetite. Many individuals simply don’t feel like eating, even when they haven’t eaten in a while.[7][8][11]
Digestive symptoms can include nausea and vomiting, gas, bloating, and changes in bowel movements. The pancreas produces enzymes needed to digest food, so when cancer affects the organ, digestion can become impaired.[7][8]
Other symptoms may include persistent tiredness or fatigue, a swollen gallbladder, blood clots, and new-onset diabetes, especially in people over 50 years old who have no other risk factors for diabetes. Healthcare providers might suspect pancreatic cancer if a patient has recently developed diabetes or pancreatitis.[7][8]
Because early pancreatic cancer may not have any signs or symptoms, regular checkups can be important for those at high risk. These checkups may show subtle signs on bloodwork or during a medical exam. Anyone experiencing persistent abdominal pain, unusual-colored bowel movements, jaundice, unexplained weight loss, or feeling weak and sick should contact a doctor promptly.[5]
Prevention: Reducing Your Risk
While there is no guaranteed way to prevent pancreatic ductal adenocarcinoma, adopting a healthy lifestyle can help reduce the risk. Making certain changes to daily habits may lower the chances of developing this disease.[17]
Quitting smoking is one of the most important steps a person can take. Smoking is a known risk factor for pancreatic cancer, and quitting can have many benefits, including reducing the risk of cancer. Strategies to quit include nicotine replacement therapy, counseling, and support groups. Because smoking increases risk two-fold, avoiding tobacco in all forms is critical.[7][8]
Maintaining a healthy weight through balanced eating and regular physical activity is another key preventive measure. Eating a diet that includes a variety of fruits and vegetables, choosing whole grains over processed grains, and limiting or avoiding red and processed meats can support overall health. Reducing intake of sugary drinks, high-fat foods, and alcohol also helps lower risk.[7][17]
Staying physically active is beneficial for many reasons. Regular exercise can improve mood, energy levels, and overall physical health. Aim for at least 30 minutes of physical activity per day. Activities such as walking, swimming, and yoga are good options. Gradually incorporating exercise into a daily routine can help build strength and endurance.[7][17]
For people with a family history of pancreatic cancer or a genetic syndrome that increases cancer risk, talking to a doctor about screening programs and genetic testing may be helpful. Although there are no routine screening tests for the general population, those at elevated risk may benefit from specialized monitoring.[5][11]
Pathophysiology: How the Disease Develops
Pancreatic ductal adenocarcinoma develops when cells in the ducts of the pancreas undergo changes that cause them to grow and divide abnormally. These cells that line the ducts normally produce and transport digestive enzymes. When mutations occur in their DNA, these cells can begin to multiply out of control, forming a mass of abnormal tissue called a tumor.[1][3]
The disease begins at the cellular level with genetic changes. The KRAS gene, which plays a crucial role in controlling cell growth and death, is mutated in the vast majority of pancreatic cancers. When this gene is altered, it sends continuous growth signals to cells, even when they should stop dividing. Other genes in the same signaling pathway may also be affected, contributing to uncontrolled cell growth.[4]
As the tumor grows, it can invade nearby tissues and organs. Pancreatic tumors are particularly aggressive and often spread beyond the pancreas before causing noticeable symptoms. The pancreas is surrounded by other organs including the small intestine, liver, and spleen, which makes early changes hard to detect. By the time symptoms appear, the cancer has frequently spread to lymph nodes, blood vessels, or distant organs like the liver and lungs.[7][12]
One unique feature of pancreatic ductal adenocarcinoma is its tumor microenvironment. Pancreatic tumors contain a relatively low percentage of cancer cells compared to cells from normal or surrounding tissue. They also develop a dense tissue around the tumor called stroma, which can make it harder for treatments to reach the cancer cells. This characteristic poses a particular challenge for diagnosis and treatment.[2][4]
The pancreas makes enzymes that help break down fats, carbohydrates, and proteins in food. When cancer affects the pancreas, it can disrupt the production of these enzymes, leading to digestive problems. The organ also produces insulin and glucagon to maintain blood sugar levels. Tumors can interfere with these hormone-producing cells, sometimes causing new-onset diabetes.[7]
Pancreatic cancer often spreads through the bloodstream or lymphatic system to distant parts of the body, a process called metastasis. Common sites of spread include the liver, lungs, and abdominal cavity. Once the cancer has metastasized, it is classified as Stage 4 pancreatic cancer and is not curable by surgery.[7]
Research has identified specific patterns in pancreatic cancer cells that help classify the disease into subtypes. Scientists have found signatures of microRNAs, long noncoding RNAs, and DNA methylation that are characteristic of different subtypes of pancreatic cancer, such as basal-like and classical subtypes. Understanding these patterns may help guide treatment decisions in the future.[4]
